跳至主要内容
临床试验/JPRN-UMIN000004487
JPRN-UMIN000004487已完成2 期

Phase II Trial of Preoperative Chemotherapy and Bevacizumab in Patients With Stage IIIA Non-Squamous Non-Small Cell Lung Cancer - Phase II Trial of Preoperative Chemotherapy and Bevacizumab

Osaka International Cancer Institute0 个研究点目标入组 30 人开始时间: 2010年11月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 74years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Active double cancer 2)Current history of hemoptysis 3)Evidence of bleeding diathesis or coagulopathy 4)With great vessel invasion 5)Cavity in tumor 6)History of uncontrollable pericardial effusion 7)History of severe heart disease 8)Current or previous history (within the last 1 year) of symptomatic cerebrovascular disease 9)Active infectious disease in need of intravenous administration of anti-bacterial, anti-fungal, or anti-viral drugs 10)Receiving anticoagulant drug (except Aspirin within 324 mg/day) 11)Uncontrollable Gastrointestinal ulceration 12)Current or previous(within the last 1 year)history of GI perforation 13)Uncontrollable systemic disease (hyper tension or diabetes mellitus) 14)Interstitial pneumonia or pulmonary fibrosis detectable on chest Xp 15)Peripheral neuropathy > Grade2 16)With a history of drug sensitivity 17)History of pregnancy or lactation 18)No intention to practice birth control 19)Patients whose participation in the trial is judged to be inappropriate by the attending doctor

研究者

相似试验